Posted by admin on Feb 28, 2021 in |
Deracoxib is a coxib class of Non Steroidal Anti-Inflammatory Drug (NSAID). Like other NSAIDs, its effects are caused by inhibition of Cyclooxygenase (COX) enzymes. Deracoxib causes greater inhibition of COX-2 than of COX-1. The aim of this proposed method was to develop and validate the UV spectrophotometric method for the routine quality control check of API containing 25 mg Deracoxib intablets dosage form. To investigate the most preferable dissolution method includes dissolution media as pH 6.8 sodium phosphate buffer + 1 % Sodium Lauryl Sulphate, 900ml, temperature as 37±0.5°C, RPM as 75, time 45 min. The absorbance maximum of Deracoxib was found to be 255nm. The concentration range of the proposed method was 5-15µg/ml and linearity as r2 = 0.9959.The result of intraday &interday precision was 0.1458% and 0.1214% RSD respectively. The results of the percentage recoveries were 99.2%, 99.3%, and 99.1%. The effective dissolution method was developed and validated by UV spectrophotometer which used to be more applicable in various pharmaceutical...
Read More
Posted by admin on Feb 28, 2021 in |
The present study was aimed to formulate and evaluate floating microspheres of Baclofen. The research work’s objective was to retain Baclofen in the stomach for a prolonged period of time, which has absorption window in the upper gastrointestinal tract. The microspheres were prepared by solvent evaporation technique. A 32 full factorial was applied to investigate the combined effect of the two independent variables, i.e., the concentration of Eudragit RL100 (X1) and concentration of Eudragit RS 100 (X2) on the dependent variables particle size (Y1), percentage drug entrapment efficiency (Y2), percentage buoyancy (Y3), in-vitro drug release at 1 h (Y4), in-vitro drug release at 6 h (Y5). Results of the multiple regression analysis revealed that in-vitro drug release decreased and particle size, percentage drug entrapment efficiency, percentage buoyancy was increased with increasing the concentration of Eudragit RL100 and Eudragit RS100. The optimized formulation has a particle size of 115.96 µm, percentage drug entrapment of 90.06%, and buoyancy of 90.76%. In-vitro drug release of Baclofen floating microspheres showed a sustained release...
Read More
Posted by admin on Feb 28, 2021 in |
Envenoming and deaths resulting from snakebites are particularly important public health problems in the rural tropics. Snake envenomation is included since 2009 in the World Health Organization (WHO) list of Neglected Tropical Diseases, as this condition remains largely neglected by national and international health authorities. The only available specific treatment is antivenom therapy, which consists of a pool of neutralizing immunoglobulins purified from the plasma of animals that are hyperimmunized against snake venom and specific toxins. However, the antivenom has some limitations, such as the poor ability to treat local effects, risk of immunological reactions, high cost, and difficult access in some regions. Therefore, the search for complementary therapies to treat snakebites is relevant, and the use of medicinal plants against snakebites is a historical practice throughout human history, and this knowledge has been transferred among the rural communities from generation to generation. Though tribal groups, forest dwellers, and rural people possess unique knowledge about plants and their uses, they are dwindling in number, and the younger generation is...
Read More
Posted by admin on Feb 28, 2021 in |
The protein MTA1 with histone deacetylase activity is a member of the nucleosome remodeling complex encoded by the mta1 gene is frequently overexpressed in biologically aggressive epithelial neoplasms. MTA1 is a nuclear co-regulatory molecule that is highly expressed in many cancers and correlates with tumor metastasis and progression. MTA1 alters signaling events in the tumor micro-environment. MTA1 contributes to cancer progression, may serve as a biomarker and therapeutic target for cancer. The main objective of this study is to perform in–silico docking studies and energy minimizations for active sites of mutated MTA1 protein by selecting different naturally available antioxidant molecules in foods to facilitate ligand-binding site interactions and identify the best from the selected...
Read More
Posted by admin on Feb 28, 2021 in |
Staphylococcus aureus is a frequent colonizer of the human body as well as a serious human pathogen. It can cope with stress factors and acquire resistance to antibiotics, thus rendering treatment difficult. Discovering new treatments for this disease is urgently required, especially in view of the emergence of multiple drug resistant organisms and to reduce the total duration of current treatments. Exfoliative toxin A (ETA), produced by Staphylococcus aureus causes scalded skin syndrome which is characterized by the separation of layers of skin. It affects newborns and adults primarily. Hence, therapies for Staphylococcal scalded skin syndrome (SSSS) are critically needed. Seeking a more effective compound for the treatment has been one of the great interests. In the present study, compounds from different plant extracts are permissible to interact with ETA using Schrodinger. The best effective compound gymnemic triacetate was selected from the list of different compounds based on its docking score and binding energy. The result showed that the herbal compound gymnemic triacetate possesses anti-bacterial activity by blocking exfoliative...
Read More
